Arkolith/Insider Trading/ELV/Form 4

Haytaian Peter D

EVP & Pres Carelon & CarelonRxElevance Health, Inc. (ELV) · full profile →Form 4 · filed Mar 5, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2025Grant(A)3K—$022K
Mar 3, 2025Tax withholding(F)2K$395.50$902K19K
Mar 3, 2025Grant(A)4K—$026K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2025Grant(A)12K—$012K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001156039-25-000026) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML